684285-11-8

Upstream product

• 684284-46-6 7-(4-fluoro-benzyl)-6,9-dihydroxy-5-methoxy-6,7-dihydro-pyrrolo[3,4-g]quinolin-8-one 
• 684284-61-5 carbonic acid 9-benzhydryloxy-7-(4-fluoro-benzyl)-6,8-dioxo-7,8-dihydro-6H-pyrrolo[3,4-g]quinolin-5-yl ester ethyl ester 
• 684285-09-4 9-benzhydryloxy-7-(4-fluoro-benzyl)-5-methoxy-pyrrolo[3,4-g]quinoline-6,8-dione 
• 684284-62-6 9-benzhydryloxy-7-(4-fluoro-benzyl)-5-hydroxy-pyrrolo[3,4-g]quinoline-6,8-dione 
• 684284-30-8 carbonic acid ethyl ester 7-(4-fluoro-benzyl)-9-hydroxy-6,8-dioxo-7,8-dihydro-6H-pyrrolo[3,4-g]quinolin-5-yl ester 
• 684284-29-5 7-(4-fluoro-benzyl)-5,9-dihydroxy-pyrrolo[3,4-g]quinoline-6,8-dione 

Downstream Products

• 922159-65-7 C₂₀H₁₄F₄N₂O₅S 
• 922159-67-9 C₁₉H₁₅FN₂O₂ 

Relevant academic research and scientific papers

Design, synthesis, and SAR studies of novel and highly active tri-cyclic HIV integrase inhibitors

A novel class of tri-cyclic HIV integrase inhibitors were designed based on conformational analysis of 1,6-naphthyridine carboxamide compound L-870810 and docking the designed inhibitor into the active site of our integrase enzyme model. The efficient syn

PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS

Novel HIV integrase inhibitor compounds having at least one phosphonate group, protected intermediates thereof, and methods for inhibition of HIV-integrase are disclosed.